These molecules further drive Treg proliferation and migration through the MAPK/CDK4/6/Rb and STAT3/SIAH2/P27 pathways, reinforcing the immunosuppressive nature of the TME and accelerating tumor progression (31). The gene discussed is STAT3; the disease is neoplasm.